Funds raised by Bridge the Gap Walk hit half a million
More than 2000 walkers were treated to a spectacular and memorable walk last Sunday (9 September). The family friendly Bridge the Gap Walk took in six of Cambridge’s famous Colleges and the recently reopened Museum of Zoology.
Pull up a chair as binge-watching gets serious
Academics from across the world will meet in Cambridge this week to discuss the very modern phenomenon of binge-watching – one of the most talked-about cultural developments of the 21st century.
Cutting-edge microscope revealed at opening of new £5m structural biology centre
The Medical Research Council-University of Glasgow Centre for Virus Research (CVR) opened an innovative new structural biology centre yesterday (Tuesday), home to a cutting-edge JEOL CryoARM 300, the first cryo-electron microscope of this model in the United Kingdom, which will be used to image biological molecules at near atomic level.
Mentoring can reduce anxiety, says study
Mentoring of junior colleagues can reduce anxiety and improve the mental health of the mentors themselves, finds a new study co-authored by Dr Thomas Roulet of Cambridge Judge Business School.
The karma of business, based on a haircut and a floral basket
Is the hard nosed, cold eyed world of business aloof from the concept of karma, or is there a real return to be had in helping others?
2018 Max Perutz Science Writing Award shortlist announced
Ten outstanding articles have been shortlisted for this year’s Max Perutz Science Writing Award, the MRC’s annual writing competition.
DefiniGEN strengthens Board with appointment of Professor Sir John Savill
DefiniGEN, the world leader in human iPSC differentiation and disease modelling, announces the appointment of Professor Sir John Savill as a Non-Executive Director of the Board.
Heidi Allen MP opens inkjet specialist’s new office following meteoric growth
Meteor has expanded into a new location at Harston Mill near Cambridge. Heidi Allen MP officially opened the company’s new office last week.
Darktrace launches Antigena Version 2
More Organizations Fight Back with Autonomous Response AI as Antigena v2 Announced
Cambridge Innovation Capital leads AudioTelligence’s seed funding
Cambridge Innovation Capital has led a £3.1 million seed funding round into AudioTelligence Limited, a company delivering real-time audio processing technology for the enhancement of Automatic Speech Recognition (ASR) systems.
Fund Twenty8 opens for investment to the public for two weeks only
After numerous requests from SyndicateRoom investors, Fund Twenty8 – the world’s first algorithmically-driven EIS fund – will open again for investment today (11th September) for two weeks only.
Cambridge Network celebrates its 21st birthday
Cambridge Network members and guests filled the new ballroom of the University Arms Hotel last week to celebrate the Network's 21st birthday.
Cambridge Index eases 1.7%
The Cambridge Index dropped 519.3 points or 1.7% to close at 27,730.6, as four of the top five Index heavyweights posted weekly losses to their share prices.
New term, new opportunities for learning
Has the new school term prompted you to think about learning more or improving your professional skills? If so, Cambridge Network's Learning Collaboration offers a range of courses over the coming months to help you boost your capabilities.
Zero emission vehicles: how reality can match the ambitions
What will speed up the transition to zero emission vehicles? The CBI asked businesses what they already doing - and what they need to happen next...
Meet Frankie, Sookio's new Digital Marketing Assistant
The Sookio team has expanded with the addition of a new Digital Marketing Assistant, Frankie Weaver.
Expedeon AG announces commercial-use licence of proprietary technology in diagnostic assay
Heidelberg, Germany and Cambridge, UK... –Expedeon AG today announced the signing of a licence and supply agreement for its colloidal gold with South Korea-based PaxGenBio, a privately held, independent developer and supplier of rapid, highly sensitive multiplex diagnostic kits.
CyanConnode sees increasing opportunities as results are published
CyanConnode (AIM: CYAN), a world leader in narrowband radio frequency (RF) mesh networks, announces its half yearly results for the six months ended 30 June 2018.
Report reveals Cambridge is one of the best places to start a business
A new report has revealed British cities where small business prospects are on the rise - and Cambridge weighs in at number three.
Accelerate@Babraham attracts additional support from Taylor Vinters and Silicon Valley Bank
The Babraham Research Campus is delighted to announce Taylor Vinters and Silicon Valley Bank as the latest organisations to pledge support for the Babraham Research Campus’ life-science accelerator, Accelerate@Babraham.
IT Governance achieves a world first with accredited ISO 27001 certificate
Certification Europe has recertified IT Governance to IS0 27001 which, most importantly, references BS 10012:2017 and is a world first.
New EACH shop comes to Ely
East Anglia’s Children’s Hospices (EACH) is excited to announce another addition to its retail portfolio in Cambridgeshire.
Qualitetch completes ISO AS9100 Rev D aerospace accreditation
Qualitetch is pleased to announce that following recent audits, it has now achieved the revised ISO AS9100 Rev D standard aerospace accreditation with NQA. ISO AS9100 Rev D is a single common quality management standard for the aviation, space and defence industries, and used and supported by the world’s leading aerospace companies throughout their supply chains.
Darktrace in ‘Sunday Times Tech Track 100’ for third year running
World-Leading Cyber AI Company Named One of Britain’s Fastest Growing Tech Companies
Arecor secures £6m investment for clinical development of its diabetes portfolio
Arecor Ltd, the UK-based leader in developing superior biopharmaceuticals through the application of an innovative formulation technology platform, today announces that it has secured £6 million of investment from new and existing investors for the clinical development of the Company’s speciality pharma portfolio of proprietary diabetes products.